OPG inhibits RANK–RANKL interactions, thus suppressing osteoclastogenesis and bone resorption [35], and there was no difference in OPG levels between medicated patients with MDD and healthy controls in this study. This evidence concerns the gene TNFRSF11B and major depressive disorder.